MALAT1 and Hepatic fibrosis: These results indicate that plasma EVs-Lnc-MALAT1 is a potential biomarker for liver fibrosis, especially for high liver fibrosis, although the sample size was small and plasma Lnc-MALAT1 and other biomarkers were not included in the current study.